Dyne Therapeutics (DYN) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.05
-0.94
-0.84
-0.73

Details

Expected EPS
-0.772292
Actual EPS
-0.73
Surprise EPS
0.04
Surprise Percent
+5.48%

Description

⁨Dyne Therapeutics⁩ (⁦DYN⁩) has reported earnings of ⁦-0.73⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts